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Abstract objective To illustrate the method of cohort reporting of persons with diabetes mellitus (DM) in a
primary healthcare clinic in Amman, Jordan, serving Palestine refugees with the aim of improving
quality of DM care services.
method A descriptive study using quarterly and cumulative case ﬁndings, as well as cumulative and
12-month analyses of cohort outcomes collected through E-Health in UNRWA Nuzha Primary Health
Care Clinic.
results There were 55 newly registered patients with DM in quarter 1, 2012, and a total of 2851
patients with DM ever registered on E-Health because this was established in 2009. By 31 March 2012,
70% of 2851 patients were alive in care, 18% had failed to present to a healthcare worker in the last
3 months and the remainder had died, transferred out or were lost to follow-up. Cumulative and
12-month cohort outcome analysis indicated deﬁciencies in several components of clinical care:
measurement of blood pressure, annual assessments for foot care and blood tests for glucose, cholesterol
and renal function. 10–20% of patients with DM in the different cohorts had serious late complications
such as blindness, stroke, cardiovascular disease and amputations.
conclusion Cohort analysis provides data about incidence and prevalence of DM at the clinic level,
clinical management performance and prevalence of serious morbidity. It needs to be more widely
applied for the monitoring and management of non-communicable chronic diseases.
keywords diabetes mellitus, Palestine refugees, Jordan, cohort reports
Introduction
The global burden of diabetes mellitus (DM) is immense
and increasing. In 2011, there were an estimated 366
million people living globally with DM, of whom 183
million (50%) were undiagnosed (International Diabetes
Federation 2011). Complications due to DM are a major
cause of disability and diminished quality of life; in 2011
an estimated 4.6 million people died of DM. Driven by
changes in socio-economic conditions, urbanisation, Wes-
tern-style diets and physical inactivity, the global preva-
lence of DM is expected to reach 552 million by 2030.
In many parts of the world, unstructured and unmon-
itored clinical care of DM is the norm, and there is little
regular or reliable information from health facilities about
DM incidence and prevalence, treatment outcomes, asso-
ciated morbidity or mortality. We have argued previously
that this unsatisfactory situation can be rectiﬁed and
that the ‘cohort’ recording and reporting systems adapted
from the DOTS (directly observed therapy, short course)
framework for tuberculosis control can be used to monitor
chronic disease such as DM (Harries et al. 2008). In
Malawi, the DOTS system has been successfully used for
monitoring the treatment of HIV⁄AIDS (Harries et al.
2009a) and to monitor case burden and treatment out-
comes in patients with DM in a central referral hospital
(Allain et al. 2011).
The United Nations Relief and Works Agency for
Palestine Refugees (UNRWA) has been working in the
Near East for 62 years, and provides health, education and
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Jordan, Lebanon, Syria, the West Bank and Gaza Strip
(UNRWA 2011). It currently delivers health services
through 138 primary healthcare (PHC) centres and one
hospital in the West Bank, and the main focus of its health
work is the provision of general medical care, maternal and
child health care and diagnosis and treatment of non-
communicable diseases, particularly DM and hypertension.
Prevalence of DM and hypertension among the served
population aged 40 years and above attending the health
facilities is 11.4% and 17.5%, respectively, and in 2011
almost 211 000 people with DM and⁄or hypertension
were being cared for at UNRWA clinics in the region
(UNRWA 2011).
In one of the primary healthcare clinics, Nuzha PHC, in
Jordan, we have previously described the use of cohort
reporting in Palestine refugees with hypertension (Khader
et al. 2012). From the same clinic, we now describe the use
of quarterly reporting for cases and treatment outcomes to
assess the burden of disease and management of patients
with DM, and we discuss how these data can inform and
improve DM care services in the clinic.
Methods
Design and Setting
This is a retrospective descriptive study of the cohort
reporting framework to monitor burden of disease and
management of persons with DM at Nuzha PHC Clinic.
The study was conducted in Nuzha PHC Clinic in Amman
(Khader et al. 2012). In Jordan, a country of 6 million
people, there are 2 million registered Palestine refugees, of
whom 17% live inside 10 ofﬁcial camps. UNRWA has 24
PHC clinics in Jordan. Through these clinics, the organi-
sation serves all registered Palestine refugees in the country,
of whom 53% access UNRWA services. Nuzha PHC clinic
is located outside of the camps and serves a catchment
population of approximately 55 000 refugees. The refugees
in the catchment area are Arab-Palestinians with Jorda-
nian nationality, the refugees and descendants having lost
their normal place of residence in Palestine as a result of the
1948 Arab-Israeli conﬂict. The refugees are usually of
middle- and low-income class, predominately profession-
als, employees, skilled and unskilled labourers and with
high unemployment rates in women. There is good food
security with generally a balanced Mediterranean diet rich
in cereals, vegetables, legumes and fruits. However, while
macro-nutrition deﬁciency is rare, micronutrient deﬁ-
ciency is common among women and children. Rates of
cigarette smoking are high and regular physical activity is
uncommon. The population is generally young with a low
rate of illiteracy, and regular attendance for preventive
health care such as vaccination uptake, antenatal visits,
post-natal care and health screening programmes is the
norm. Major communicable diseases (e.g., TB and
HIV⁄AIDS) are under control, but with life expectancy
becoming longer, there is an increasing incidence of non-
communicable diseases, especially DM and hypertension.
The catchment population attends Nuzha PHC Clinic,
which is staffed by four doctors and a variable number of
nurses and support staff. All screening, diagnosis and
treatment services at the clinic are provided free of charge.
Persons with DM and their management: Palestine
refugees who attend the clinic are screened annually for
DM and 6-monthly for hypertension if they are 40 years or
older, if they are judged to be at risk for non-communi-
cable diseases and if they are pre-conception or pregnant
women. DM screening is performed by measuring random
blood glucose (RBG) upon attendance at the clinic, and if
this is ‡126 mg⁄dl, the diagnosis is conﬁrmed⁄refuted
within a week through two fasting blood glucose (FBG)
measurements, both of which must be ‡126 mg⁄dl for a
conﬁrmed diagnosis of DM (WHO 2006; UNRWA 2009).
Those with an FBG between 110 and 125 mg⁄dl are
further screened for DM using an oral glucose tolerance
test.
Persons diagnosed with DM are clinically assessed for
complications and co-morbidities such as hypertension
(deﬁned as a blood pressure of 140⁄90 mmHg or above),
and these along with demographic and clinical information
are recorded in a patient registration ﬁle and the E-Health
system. Patients are categorised into three main groups
DM Type 1, DM Type 2 and DM + Hypertension and
further classiﬁed as new or previously diagnosed and
diagnosis made within or outside of the UNRWA system.
A record is also made about whether the patient has been
transferred in from another UNRWA clinic.
Patients are managed according to a standard algorithm
with diet and lifestyle advice, oral hypoglycaemic drugs
(glibenclamide, glicazide and metformin) and insulin and
are assessed as having controlled or uncontrolled DM,
based on measurements of 2-h post-prandial blood glucose
(PPBG). Patients with uncontrolled DM are seen weekly or
monthly until their 2-h PPBG drops below 180 mg⁄dl.
The follow-up schedule for patients with controlled DM is
to see them at the clinic every 3 months, and during this
clinic visit, the patients are assessed as follows: body mass
index, urine for glucose and albumin, measurement of 2-h
PPBG and blood pressure and the presence⁄absence of
late complications (deﬁned as blindness, end-stage renal
failure, myocardial infarction, congestive cardiac failure,
stroke and above-ankle amputation). Once a year, all
patients DM are also expected to have a foot examination,
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cholesterol and serum creatinine.
In 2009, UNRWA started an electronic health record
system (E-Health), which is operational in 6 PHC clinics
in Jordan, including Nuzha PHC Clinic. The electronic
health system is used to monitor non-communicable
diseases, maternal health, child health and general
outpatients (Khader et al. 2012). In brief, all clinical
information is recorded using electronic keyboard-
operated work stations that are set up in every clinic
room, including the pharmacy and laboratory, and these
are connected to a central server that stores the data. The
healthcare workers in the clinic use the password-
protected computers to enter patient information during
clinical encounters at the point-of-care. Patients are all
given health cards and identiﬁcation numbers, and these
are used to trace the electronic data. The E-Health system
is a tool to facilitate good clinical care and also allows
cohort data to be collected and analysed.
Patient population
All patients who were registered and entered into the
E-Health system with DM from 1 October 2009 to 31 March
2012 in Nuzha PHC Clinic were included in the study.
Source of data, variables, cohort reporting formats and
analysis
The data for the patients were obtained from the Clinic
E-Health system. Data variables for the cohorts included
age, sex, category of DM including whether there was
associated hypertension, new or previous diagnosis of
DM, place of diagnosis, whether the patient has been
transferred in from another UNRWA clinic, current
outcome status as of 31 March 2012, current manage-
ment, quarterly blood pressure measurements, whether
quarterly or annual screening tests and blood tests had
been conducted along with their results and the presence
or absence of late complications. The deﬁnitions of
variables for the management of patients and for the
cohort reports are shown in Table 1 and are similar to
what has been described previously for hypertension
(Khader et al. 2012).
For this study, data were collected, aggregated and
presented in four cohort reports: (i) Quarterly Registration
(patients with DM newly registered between 1 January
2012 and 31 March 2012; (ii) Cumulative Registration
(total number of patients with DM ever registered up to
31 March 2012, including the new quarterly registrations);
(iii) Cumulative Outcomes (outcomes of all patients with
DM ever registered up to 31 March 2012, with the
outcomes censored on March 31st); and (iv) 12-month
outcome analysis (the outcomes of patients with DM who
were newly registered in quarter 1, 2011, with data
censored on 31 March 2012). Comparisons between
groups were made using the chi-squared test with a 5%
level of signiﬁcance.
Ethical approval
The data for the study included retrospectively collected
routine patient information on DM. Data were aggregated
for the cohort reporting, and no individual patient iden-
tiﬁers were used. Approval for the study was obtained from
UNRWA Headquarters, and ethical approval for reporting
on the study was obtained from the Union Ethics Advisory
Group.
Table 1 Deﬁnitions for the management and recording of patients with diabetes mellitus (DM) for the cohort reports
Quarterly and cumulative registrations
New diagnosis Date of registration occurs within 4 weeks of date of diagnosis
Previous diagnosis Date of registration occurs 4 weeks or later from date of diagnosis
Transferred in Previously registered in another UNRWA clinic and now transferred to the current clinic
Hypertension Blood pressure more than 140⁄90 mmHg on two or more occasions
Cumulative treatment outcomes
Remaining in care Alive and in care and seen by a doctor or nurse during quarter 1, 2012
Dead Died at any time from any cause
Transferred out Permanently transferred out from the clinic to another clinic
No quarterly attendance Not seen in the clinic in quarter 1, 2012, by a doctor or a nurse
Lost to follow-up No quarterly attendances on four consecutive occasions at the clinic
12-month survival analysis
Diabetes in control 2 of the last 3 post-prandial blood glucose measurements (PPBG) £180 mg⁄dl
Diabetes out of control 2 of the last 3 post-prandial blood glucose measurements (PPBG) >180 mg⁄dl
Diabetes undetermined 2 or more post-prandial blood glucose (PPBG) measurements not carried out in last 3 visits
and <3 PPBG readings in a year, at the time of assessment
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The four cohort analyses and the results from Nuzha PHC
Clinic are shown in Tables 2–5. Table 2 shows that 85%
of new registrations were 40 years or older, 40% were new
diagnoses and more than two-thirds of patients with DM
already had hypertension at the time of registration. Of the
2851 patients with DM ever registered at Nuzha PHC
because E-Health was set up, the majority of patients were
at least 40 years old, similar to new registrations, but there
were some signiﬁcant differences in that there were more
patients with a known diagnosis of DM and more patients
diagnosed within the UNRWA system (P < 0.05)
(Table 3).
The outcomes of the whole cumulative cohort with data
censored on 31 March 2012 (Table 4) reveal two valuable
programme performance indicators for the last quarter:
42% had post-prandial blood glucose measured and 50%
had normal blood glucose. Of those diagnosed with
hypertension, 63% had blood pressure measured and 75%
had a normal reading.
Finally, a quarterly cohort outcome analysis on patients
with DM newly registered 1 year previously (January to
March 2011) and assessed in quarter 1, 2012 (Table 5)
show that in terms of recommended annual assessments,
while the blood tests for cholesterol and creatinine were
well performed, very few patients had their foot care
examinations and there were no data on whether
ophthalmic examinations had been carried out.
Discussion
This is the ﬁrst report from a primary healthcare clinic
setting to show how the DOTS cohort monitoring system
can be adapted and used to monitor and report on persons
with DM in Jordan. As is the case in patients who have
hypertension (Khader et al. 2012), this information is
useful for the UNRWA diabetes care services and can
provide information that is relevant to disease manage-
ment, assessing programme performance, patient outcomes
and long-term healthcare impact (Table 6).
The report on patients newly registered in the DM clinic
during a quarter provides informative data on ‘new
incident cases presenting to the clinic’, and this information
can be compared with the data on the cumulative number
of registered patients who have presented at the clinic,
allowing healthcare providers to assess over time whether
patient characteristics of clinic attenders is changing.
Ongoing community awareness programmes are trying to
Table 2 Quarterly Cohort Registration of patients with diabetes
mellitus (DM) (January to March 2012)
Patient characteristics Number %
Patients with DM newly registered
in the quarter
55
Gender
Male 31 56
Female 24 44
Age Group in years: at time of registration
<20 2 4
20–39 6 11
40–59 32 58
60 and above 15 27
Category of Disease: at the time of registration
DM Type 1 alone 2 4
DM Type 2 alone 16 29
DM Type 2 and Hypertension 37 67
Diagnosis
New 22 40
Previous 33 60
Place of Diagnosis
Inside UNRWA 22 40
Outside UNRWA 33 60
Transferred in 0 0
DM, diabetes mellitus; UNRWA, United Nations Relief and
Works Agency for Palestine Refugees in the Near East.
Table 3 Cumulative Cohort Registration Cohort of patients with
diabetes mellitus (DM) (patients ever registered up to 31st March,
2012)
Patient characteristics Number %
All patients with DM ever registered,
including the newly registered, up to
31 March 2012
2851
Gender
Male 1314 46
Female 1537 54
Age Group in years: at time of registration
<20 43 2
20–39 263 9
40–59 1670 59
60 and above 875 30
Category of Disease: at time of registration
DM Type 1 alone 70 2.5
DM Type 2 alone 585 20.5
DM Type 2 and Hypertension 2196 77
Diagnosis
New 777 27
Previous 2074 73
Place of Diagnosis
Inside UNRWA 2126 75
Outside UNRWA 725 25
Transferred in 95 3
DM, diabetes mellitus; UNRWA, United Nations Relief and
Works Agency for Palestine Refugees in the Near East.
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styles and thus patients may be less affected by complica-
tions at the time of diagnosis and registration. The
frequency of new quarterly cases at the clinic and
co-morbidity at the time of registration and tracked over
time may indicate the success or otherwise of these
community-based prevention strategies.
The cumulative number of patients alive and remaining
in care at set moments in time is another vital piece of
strategic information that indicates prevalent disease at
the clinic (Harries et al. 2009b), and this can help clinic
staff to make rational logistic plans and forecasts for
consumables and drugs based on accurate numbers of
patients in care. ‘Lost to follow-up’ status means no
attendance at the clinic for 12 consecutive months, and
operational research could usefully be performed to
determine why patients have failed to attend. This type of
analysis may also identify barriers and thereby solutions
to service delivery.
Of more relevance to immediate management is the
number of patients who failed to attend the clinic in the
quarter. E-Health could be used to identify and ﬂag these
patients, and, with the use of mobile phone technology,
attempts could be made to ensure the patients attend the
next quarter so that continuity of care and uninterrupted
drug intake are maintained. Mobile phone technology has
been used successfully in low- and middle-income countries
to improve the long-term follow-up of HIV-infected
patients on antiretroviral therapy (Chi & Stringer 2010;
Lester et al. 2010), and operational research could be
performed to assess whether the same success can be
achieved in the management of non-communicable diseases
such as diabetes, especially in reducing losses to follow-up
and failure to attend clinic appointments.
Of patients who did attend the clinic in the last quarter, a
sizeable proportion failed to have postprandial blood
glucose measurements, and in those with known hyper-
tension, a proportion failed to have their blood pressure
recorded. At the moment, it is uncertain whether these
apparent clinical management failures are errors of
recording or non-adherence to UNRWA guidelines
(UNRWA 2009), but on both counts, the two pieces of
data indicate a need for improved performance of either
E-Health and⁄or patient management. If related to patient
management, consideration needs to be given to simpler
ways of assessing blood glucose control. For example,
measurement of glycosylated haemoglobin (HbA1C),
although more expensive than measurement of post-
prandial blood glucose, is quicker, does not need repeat
visits and provides a better index of blood glucose levels
over a period of 2–3 months (Kumar et al.2010; WHO
2011). Ideally, every patient should have these measure-
ments of blood glucose and blood pressure at least once
every quarter, and all attempts should be made to ensure
the parameters are controlled through medication and
adherence to better lifestyles. Chronic disease requires
structured care, but this usually occurs in the setting of
high patient loads. In the future, it will be important to
identify what routine tasks can be carried out by non-
medical health professionals and what needs to be referred
to specialist attention.
Table 4 Cumulative Cohort Outcomes of patients with diabetes
mellitus (DM) (patients ever registered up to 31st March, 2012)
Patient characteristics and
treatment outcomes Number %
All patients with DM ever registered,
including the newly registered, up to
31 March 2012
2851
Principal outcome as determined on
31 March 2012
Remaining in care 1981 70
Dead 69 2
Transferred out 54 2
No attendance in quarter 1 (January to
March 2012) at the clinic
506 18
Lost to follow-up 241 8
Of patients remaining in care:
current treatment
1981
Not recorded 16 1
Diet only 116 6
Oral hypoglycaemic drugs 1326 66
Insulin 191 10
Insulin plus oral hypoglycaemic drugs 332 17
Of patients remaining in care:
measurements in quarter 1, 2012
1981
Post-prandial blood glucose
(PPBG) measured:
836 42
Post-prandial blood glucose
(PPBG) £180 mg⁄dl
415 50*
Associated diagnosis of Hypertension 1563 79
Blood pressure measured 983 63
Blood pressure <140⁄90 735 75
Of patients remaining in care:
late complications
1981
Patients with one or more
late complications
347 18
Patients who are blind 31 2
Patients with end-stage renal disease 5 <1
Patients with myocardial infarction 171 9
Patients with congestive cardiac failure 80 4
Patients with stroke 104 5
Patients with above-ankle amputation 3 <1
DM, diabetes mellitus.
*% of those who had post-prandial blood glucose measured.
% of those with an associated diagnosis of hypertension.
% of those who had blood pressure measured.
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cross-sectional snap shot of the clinic programme at a set
point in time, it is limited by the fact that the time periods
of the E-health registered patients range from years when
patients were ﬁrst diagnosed to a few days for the latest
patients being registered just before the census date on
31 March, 2012. For this reason, the 12-month cohort
outcome analysis provides a much better assessment of
treatment outcomes, clinical management performance and
quality of control for a smaller group of patients registered
over a 3-month period, in this case 1 January 2011 to
31 March 2011, with outcomes assessed 12 months in the
future. Although this is not strictly a 12-month outcome
analysis as some patients are followed for 15 months, in
the context of routine monitoring this is good enough to
inform about programme performance and assessing
whether interventions as speciﬁed in UNRWA guidelines
are being carried out on a quarterly or an annual basis,
what proportion of patients have their DM controlled and
their cholesterol and creatinine in the normal range and,
of those with hypertension, what proportion have their
blood pressure under control. Furthermore, the number
with late complications at 1 year after registration provides
a baseline assessment from which to compare serious
morbidity during longer-term follow-up.
UNRWA will collect these cohort data on a quarterly
basis, with this type of routine analysis enabling the
programme to look at whether programme performance
and disease control in later cohorts are improving and
long-term whether this makes a difference to the patients’
health status. This approach is very similar to the quarterly
cohort analysis conducted in Malawi for HIV⁄AIDS
patients on antiretroviral therapy (Libamba et al. 2006). At
each 12-month period, an annual cohort analysis can also
be conducted with more detailed information being
provided at the time.
E-Health is essential for enabling this type of cohort
analysis to work. Using paper-based registers and cards to
do manual calculation of cohorts and outcomes is time-
consuming and takes health staff away from patient care.
A real-time electronic system at the point-of-care greatly
facilitates cohort analysis, and, although setting up such a
system may appear to be a daunting proposition, it is
sometimes easier to do this de novo in low- and middle-
income countries than in more developed countries
(Douglas et al. 2010; Allain et al. 2011). There is
evidence that electronic systems can also lead to better
individual patient care as the system prompts clinicians
for complication screening and stores information on
complications in an accessible format (Douglas et al.
2010). An electronic database also provides an infra-
structural platform for audit and operational research, the
Table 5 12–15 month Cohort Outcome Analysis of patients with
diabetes mellitus (DM)*
Patient characteristics and outcomes Number %
Patients with DM newly registered in
Quarter 1 (Jan to Mar) 2011
117
Principal outcome as determined on
31 March 2012
Remaining in care 71 61
Dead 0 0
Transferred out 3 3
No quarterly attendance at the clinic in
quarter 1, 2012
43 36
Lost to follow-up 0 0
Of those remaining in care:
current management
71
Not recorded 0
Diet only 4 6
Oral hypoglycaemic drugs 54 76
Insulin 8 11
Insulin plus oral hypoglycaemic drugs 5 7
Of those remaining in care: DM control 71
Diabetes in control 41 58
Diabetes out of control 28 39
Diabetes control undetermined 2 3
Of those remaining in care: BP in current
quarter
71
With an associated diagnosis of
hypertension
51 72
Of those blood pressure measured 37 73
Of those blood pressure <140⁄90 27 73
Of those remaining in care: Annual
Assessment
71
Foot care examination carried out
during the 12 months
23
Referred to ophthalmologist during
the 12 months
No data No data
Blood total cholesterol measured
at least once in 12 months
71 100
Of those, total cholesterol <200 mg⁄dl 51 72
Serum creatinine measured at least once
in 12 months
70 99
Of those, serum creatinine <1.2 mg⁄dl 63 90
Of those remaining in care:
late complications
71
Patients with one or more late
complications
71 0
Patients who are blind 0 0
Patients with end-stage renal disease 0 0
Patients with myocardial infarction 5 7
Patients with congestive cardiac
failure
11
Patients with stroke 1 1
Patients with above-ankle amputation 0 0
*The cohort is patients newly registered with DM between 1
January 2011 and 31 March 2011 who are assessed for outcomes
in March 2012 12–15 months later.
DM, diabetes mellitus; BP, blood pressure.
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answered can lead to an improvement of programme
performance.
In conclusion, the use of cohort reporting is seen as a
valuable monitoring tool for managing DM in Palestine
refugees and provides useful, real-time data on the burden
of DM and its management at the primary clinic level.
The data sets can also serve as a useful source of
information for operational research on the introduction
of new medications, new diagnostic technologies and new
models of healthcare delivery. UNRWA will expand
cohort analysis to the other PHC clinics in Jordan that
already have E-Health as well as expand E-Health to all
PHC clinics in the country. The logistics of reporting from
the clinic level and then at the national level will be
worked out as this plan progresses. Cohort reporting and
E-health obviously requires resources, but a ‘data-rich,
information-rich’ programme should improve its
performance leading to improved patient outcomes and
better health status.
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